-
Share
02/02/23
10:30
Share
here is a list of biotech companies with emerging Head and Neck cancer Drugs Under Different Phases of Clinical Development
• CLR 131: Cellectar Biosciences, Inc.
• MEM-288: Memgen, Inc.
• IK 175: Ikena Oncology
• Tigilanol Tiglate: QBiotics Group Limited
• BNT 113: BioNTech
• Niraparib: GlaxoSmithKline
• Atezolizumab: Hoffmann-La Roche
• Xevinapant: Merck
extract from an article https://www.openpr.com/news/2891022/head-and-neck-cancer-pipeline-drugs-and-companies-insight-report
-